Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CogstateASX:CGS +7.33%80 3-Year Dividend Growth Rate is 0.00% as of Dec. 2025. GuruFocus rates ASX:CGS with a GF Score™ of 80/100 and a GF Value™ of A$2.11 (Significantly Overvalued). The stock has 4 warning signs investors should review. Among 165 Healthcare Providers & Services companies, Cogstate ranks worse than 606060% on this metric.
The historical rank and industry rank for Cogstate's 3-Year Dividend Growth Rate or its related term are showing as below:
ASX:CGS's 3-Year Dividend Growth Rate is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.9 * Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
During the past 13 years, the highest Dividend Payout Ratio of Cogstate was 0.21. The lowest was 0.00. And the median was 0.00.
2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.
Cogstate Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
AUD 0.020000
2025-08-27
2025-08-28
2025-09-29
Cash Dividend
annually
AUD:AUD 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Cogstate's Dividend Yield (%) for Today is calculated as
Current Share Price is A$2.93.
Cogstate's Dividends per Share for the trailing twelve months (TTM) ended in Today is A$0.02.
During the past 13 years, the highest Dividend Yield of Cogstate was 0.73%. The lowest was 0.00%. And the median was 0.00%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cogstate 3-Year Dividend Growth Rate Related Terms>
ASX:CGS vs VEEV, BTSG, HQY: 3-Year Dividend Growth Rate Comparison
For the Health Information Services subindustry, Cogstate's 3-Year Dividend Growth Rate, along with its competitors' market caps and 3-Year Dividend Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cogstate 3-Year Dividend Growth Rate vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Cogstate's 3-Year Dividend Growth Rate distribution charts can be found below:
* The bar in red indicates where Cogstate's 3-Year Dividend Growth Rate falls into.
This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with expontential compound based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.
What does a 3-Year Dividend Growth Rate of 0.00% mean?
Cogstate (ASX:CGS) has a 3-Year Dividend Growth Rate of 0.00% as of Dec. 2025. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Cogstate and its competitors. According to the industry distribution chart, Cogstate ranks #999999 out of 165 companies in the Healthcare Providers & Services industry.
Is Cogstate's 3-Year Dividend Growth Rate too high?
Cogstate's current 3-Year Dividend Growth Rate is 0.00%. Based on the distribution chart, Cogstate ranks #999999 out of 165 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Cogstate has a GF Score™ of 80/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cogstate's 3-Year Dividend Growth Rate compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, Cogstate ranks #999999 out of 165 companies for 3-Year Dividend Growth Rate. This places Cogstate in the lower half of its industry. The industry median 3-Year Dividend Growth Rate is 10.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year Dividend Growth Rate for a Healthcare Providers & Services company?
The median 3-Year Dividend Growth Rate among Healthcare Providers & Services companies is 10.90, based on 165 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year Dividend Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year Dividend Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year Dividend Growth Rate mean?
A high 3-Year Dividend Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year Dividend Growth Rate is the company's three-year average growth of dividend payout. View historical data on Cogstate and its competitors. For the Healthcare Providers & Services industry, the median 3-Year Dividend Growth Rate is 10.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Cogstate's current 3-Year Dividend Growth Rate is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogstate stock overvalued right now?
Based on GuruFocus' analysis, Cogstate (ASX:CGS) is currently considered Significantly Overvalued. The stock's GF Value™ is A$2.11, compared to a current price of A$2.93 — trading 38.9% above its estimated fair value. The current 3-Year Dividend Growth Rate is 0.00%. Cogstate's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year Dividend Growth Rate calculated?
3-Year Dividend Growth Rate is calculated from a company's financial statements. For Cogstate (ASX:CGS), the current 3-Year Dividend Growth Rate is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Cogstate (ASX:CGS) Overvalued in 2026?
Based on GuruFocus' analysis, Cogstate stock appears to be overvalued.
The current stock price of A$2.93 is trading 38.9% above its estimated GF Value™ of A$2.11.
GuruFocus considers Cogstate to be Significantly Overvalued.
Key valuation signals for ASX:CGS:
3-Year Dividend Growth Rate: 0.00%
GF Value™: A$2.11 vs. price of A$2.93 (38.9% above fair value)
No single metric tells the full story. See the ASX:CGS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Cogstate Ltd is a cognitive science company. The principal activity of the group is the Creation, validation, and commercialisation of digital brain health assessments; and the Design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments and reporting. Its operating segment includes Clinical Trials, Healthcare, and Administration. The company generates maximum revenue from the Clinical Trials segment. In the clinical trials segment, technology and services are sold to pharmaceutical and biotechnology companies. The company derives revenue from the sale of licensed software and cognitive testing services.
80GF Score
Get the complete analysis for ASX:CGS
3-Year Dividend Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:CGS has been successfully added to your 
